| |
| |
|
| Insider
Information: |
Lyle Corinne H |
| Relationship: |
Director |
| City: |
Fremont |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
146,030 |
|
|
Indirect Shares
|
2,600 |
|
|
| Direct
Value |
$7,375,955 |
|
|
|
Indirect Value
|
$76,518 |
|
|
| Total
Shares |
148,630 |
|
|
| Total
Value |
$7,452,473 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 12.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Edwards Lifesciences Corp |
EW |
CVP & Pres., Global Ops |
2010-05-11 |
16,687 |
2010-02-11 |
2,600 |
Premium* |
|
|
Onyx Pharmaceuticals Inc |
ONXX |
Director |
2013-10-01 |
0 |
2008-05-28 |
0 |
Premium* |
|
|
Avanir Pharmaceuticals |
AVNR |
Director |
2014-02-12 |
80,050 |
2013-03-11 |
0 |
Premium* |
|
|
Neurocrine Biosciences Inc |
NBIX |
Director |
2018-05-07 |
43,283 |
2013-03-28 |
0 |
Premium* |
|
|
Insulet Corp |
PODD |
Director |
2023-05-23 |
6,010 |
2019-01-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PODD |
Insulet Corp |
Director |
• • – |
2023-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
843 |
6,010 |
0 |
- |
|
| PODD |
Insulet Corp |
Director |
• • – |
2022-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,009 |
5,167 |
0 |
- |
|
| PODD |
Insulet Corp |
Director |
• • – |
2021-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
808 |
4,158 |
0 |
- |
|
| PODD |
Insulet Corp |
Director |
• • – |
2021-05-13 |
4 |
S |
$231.42 |
$215,915 |
D/D |
(933) |
3,350 |
0 |
% |
|
| PODD |
Insulet Corp |
Director |
• • – |
2020-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,029 |
4,283 |
0 |
- |
|
| PODD |
Insulet Corp |
Director |
– • – |
2020-05-01 |
4 |
AS |
$196.82 |
$169,856 |
D/D |
(863) |
3,254 |
0 |
% |
|
| PODD |
Insulet Corp |
Director |
– • – |
2020-04-30 |
4 |
AS |
$195.54 |
$155,650 |
D/D |
(796) |
4,117 |
0 |
% |
|
| PODD |
Insulet Corp |
Director |
• • – |
2019-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,726 |
4,913 |
0 |
- |
|
| PODD |
Insulet Corp |
Director |
• • – |
2019-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,187 |
3,187 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2018-05-07 |
4 |
AS |
$83.13 |
$415,625 |
D/D |
(5,000) |
43,283 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2018-05-02 |
4 |
D |
$80.08 |
$105,706 |
D/D |
(1,320) |
48,283 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2018-05-02 |
4 |
OE |
$7.05 |
$105,750 |
D/D |
15,000 |
49,603 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2017-05-05 |
4 |
AS |
$53.98 |
$269,900 |
D/D |
(5,000) |
34,603 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2017-05-03 |
4 |
D |
$53.37 |
$50,808 |
D/D |
(952) |
39,603 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2017-05-03 |
4 |
OE |
$3.40 |
$51,000 |
D/D |
15,000 |
40,555 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2016-08-08 |
4 |
AS |
$48.54 |
$242,700 |
D/D |
(5,000) |
25,555 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2016-05-03 |
4 |
D |
$45.05 |
$46,041 |
D/D |
(1,022) |
30,555 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2016-05-03 |
4 |
OE |
$3.07 |
$46,050 |
D/D |
15,000 |
31,577 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2015-04-08 |
4 |
D |
$42.09 |
$71,385 |
D/D |
(1,696) |
16,577 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2015-04-08 |
4 |
OE |
$4.76 |
$71,400 |
D/D |
15,000 |
18,273 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2014-05-12 |
4 |
D |
$14.47 |
$148,433 |
D/D |
(10,258) |
3,273 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2014-05-12 |
4 |
OE |
$12.37 |
$148,440 |
D/D |
12,000 |
13,531 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2014-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
21,700 |
80,050 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-10-01 |
4 |
D |
$125.00 |
$262,500 |
D/D |
(2,100) |
0 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-07-30 |
4 |
AS |
$131.26 |
$196,890 |
D/D |
(1,500) |
2,100 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
